MAI Presents Migraine in the Workplace Seminar

By 14 October 2020Events, MAI News, Media, Press Release

Press Release

Dublin – 14 September 2020: The Migraine Association of Ireland (MAI) will present Migraine in the Workplace, a free online seminar on Friday, October 23rd from 12 pm – 2 pm.

The event is aimed at managers, business owners and employers who are interested in learning how to help their employees effectively manage migraine attacks at work.

Migraine is a complex neurological disorder and imposes a substantial burden on patients, families, employers and societies. As migraine primarily affects working‐age adults, this has important implications for both employees and employers.

”Tackling migraine in the workplace is now one of MAI’s key strategic objectives,” says MAI CEO Patrick Little. “This seminar will not only inform employers about the impact of migraine on their workforce but will also highlight practical ways that they can respond for the benefit of both their employees and their companies” he added.

The seminar is sponsored by Novartis and will showcase an internal programme devised and implemented by the company to help their employees with migraine to manage attacks at work.

Commenting, Audrey Derveloy, Managing Director, Novartis, said; “We are delighted to support Migraine Ireland’s, Migraine in the Workplace webinar. Migraine is often a misunderstood disease so it is important to raise employers’ awareness about how migraine can impact a person’s work life. This webinar will provide employers with useful tips on how they can support their employees living with migraine by creating a ‘migraine friendly’ work environment. We are excited to hear from our Global Market Access Director, Mr. Leonhard Schaetz, who will present findings from the Novartis Migraine Care pilot program. We hope that employers will see the many benefits that can arise from the rollout of these types of employee support programs in the future.’

For more information on speakers and to book a virtual ticket please visit MAI’s Eventbrite page at


Note to Editors:

Migraine generally features a one-sided throbbing headache that is episodic and lasts hour or even days with total freedom between attacks. Classical migraine (migraine with aura) may be signalled by visual disturbances in what is call the “aura” stage. This affects about 20% of migraneurs. Common migraine (or migraine without aura) and classical migraine may be accompanied by vomiting, diarrhoea, confusion and, in rare cases, temporary paralysis and loss of speech. Sensitivity to light, noise and strong smells is also frequently reported.

For media enquiries please contact

About the Migraine Association of Ireland

The Migraine Association is Ireland’s only patient charity providing support, education, information and reassurance to people suffering from migraine and other headache disorders. We provide free educational courses on self-management and understanding migraine for people with migraine, and certified health professional courses for GPs and other HCPs.

We also lobby and advocate on behalf of migraine sufferers to access new treatments and to ensure they have access to current treatments. We operate an Information Line and produce a member’s magazine three times a year with national and international news of interest to those with migraine. We also have a variety of information resources on social media and we have a selection of information leaflets including our migraine diary to help track and identify your triggers. For more information, please visit

About Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. Novartis is currently conducting over 20 clinical trials in Ireland. About 105 thousand people of more than 140 nationalities work at Novartis around the world and over 1,200 in Ireland in commercial operations in Dublin and manufacturing in Cork. Find out more at